Trump health care, flu shot, food pyramid: Morning Rounds
President Trump recently unveiled his ‘Great Healthcare Plan,’ which aims to address the rising costs of healthcare by implementing policies that would give the federal government more control over pharmaceutical companies. While the details of the plan are still unclear, some key provisions include extending lower international drug prices to all Americans, making more prescription drugs available over the counter, and sending health insurance subsidies directly to enrollees.
However, many of these proposals would require action from Congress, which has previously failed to extend enhanced Affordable Care Act subsidies, leading to a significant increase in premiums for millions of people. The administrator of the Centers for Medicare and Medicaid Services, Mehmet Oz, claims that Trump’s plan will result in savings, but the actual impact remains to be seen.
In other news, a controversial CDC-funded hepatitis B vaccine study in Africa has been canceled, sparking confusion among officials in Guinea-Bissau and at HHS. The study, which was deemed unethical by some experts, has been the subject of scrutiny since its inception in December.
Meanwhile, a new survey reveals stark partisan divides in American attitudes towards science, with Republicans showing more distrust towards scientists compared to Democrats. Despite this, trust in science has increased slightly, with scientists remaining a trusted profession.
The flu vaccine is also proving to be effective against this year’s dominant strains of the virus, offering some protection against H3N2 viruses. Early research from the UK, France, and China suggests that the vaccine is providing significant protection against these strains, despite not being specifically designed for them.
Lastly, the new U.S. dietary guidelines are being touted as both healthier and more budget-friendly than previous versions, with food economists designing affordable and nutritious diets based on the updated pyramid. Trump administration officials are promoting these guidelines as a way to improve public health and lower costs for Americans.
Overall, these developments highlight the ongoing challenges and opportunities in the healthcare and scientific sectors, as policymakers and researchers strive to improve access to affordable and effective healthcare for all.
